Contract facts
UnrestrictedNo full NAICS 339112 intel page yet. Browse NAICS intelligence
Increase Quantities by Adding Clins 1003 and 1004 is a federal Unrestricted award for W40m Usa Hca held by Avita Medical Americas, LLC. Estimated value $1M ($869K obligated). Current period of performance ends Sep 30, 2027 (potential Sep 30, 2028). Last award drew 1 bidder. Place of performance: JBSA FT SAM HOUSTON TX. Related solicitation W81K0023Q0179.
Increase quantities by adding clins 1003 and 1004. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Sep 30, 2027 (348 days remaining). Agencies typically plan 12–18 months ahead — at 11.4 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on W81K0023P0232? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordAvita Medical Americas, LLC — $13.7M obligated across 4 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81K0023P0232?
W81K0023P0232 (Increase quantities by adding clins 1003) is a W40m Usa Hca award with a potential value of $1M, currently held by Avita Medical Americas, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W81K00-23-P-0232?
W81K00-23-P-0232 is the dashed form of PIID W81K0023P0232 (Increase quantities by adding clins 1003), held by Avita Medical Americas, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W81K0023P0232?
W40m Usa Hca awarded W81K0023P0232 to Avita Medical Americas, LLC (potential $1M).
Who is the incumbent on W81K0023P0232?
Avita Medical Americas, LLC is the incumbent with $13.7M across 4 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2027.
When does Avita Medical Americas, LLC’s W81K0023P0232 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on W81K0023P0232? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.